Management Team

Peter D. Meldrum
President and CEO
Peter Meldrum

Peter D. Meldrum has been a Director of the Company since its inception in May 1991 and has been President and Chief Executive Officer of the Company since November 1991. Prior to joining the Company he was President and Chief Executive Officer of Founders Fund, Inc., a venture capital group. He received a Doctor of Engineering degree (honorary) from the University of Utah in 2009, a Doctor of Science degree (honorary) from Westminster College in 2004, an M.B.A. degree from the University of Utah in 1974, and a B.S. degree in Chemical Engineering from the University of Utah in 1970.

Mark C. Capone
Chief Operating Officer
Mark Capone Myriad Genetic Laboratories, Inc.

Mark C. Capone, Chief Operating Officer of Myriad Genetics Laboratories, joined the company in October 2002. He was previously Senior Vice President of Sales. Prior to joining Myriad, Mr. Capone served 17 years with Eli Lilly and Company where he held positions as Product Development Manager, Manufacturing Plant Manager, and Area Sales Director. Mr. Capone received his Bachelor of Science degree in Chemical Engineering from Penn State University graduating with highest distinction, his Master of Science degree in Chemical Engineering from Massachusetts Institute of Technology, and his Master of Science in Management from Massachusetts Institute of Technology.

Gregory C. Critchfield M.D.
President
Gregory Critchfield Myriad Genetic Laboratories, Inc.

Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., a wholly owned subsidiary, joined the Company in July 1998. Dr. Critchfield previously served as Senior Vice President, Chief Medical and Science Officer of Quest Diagnostics (formerly Corning Clinical Laboratories). Dr. Critchfield received his M.D. from the University of Utah and his M.S. in Biophysical Sciences from the University of Minnesota. He is Board Certified in Clinical Pathology.

James S. Evans
Chief Financial Officer
James Evans Myriad Genetics, Inc.

James S. Evans, Chief Financial Officer, joined Myriad in 1995. Mr. Evans served as Myriad's Corporate Controller from 1995 until July 2005 when he was named Vice President, Finance, a position he held until November 2007 when he was named Chief Financial Officer. Mr. Evans began his career in the Audit/Attestation division of the international accounting firm of KPMG, LLP where he held several positions. He worked as the Controller for Genmark, Inc. and Shaperite Concepts, Ltd. prior to joining Myriad. Mr. Evans received a Bachelor of Science and Master of Accounting degrees from Brigham Young University in 1987 and is a Certified Public Accountant licensed in the State of Utah.

Robert G. Harrison
Chief Information Officer
Robert Harrison Myriad Genetics, Inc.

Robert G. Harrison, Chief Information Officer, joined Myriad in 1996. Mr. Harrison served as Myriad's Network Administrator from 1996 to 2000. He was then named Director of Information Systems and Technology from 2000 until January 2005. He was then named Vice President of Information Systems and Technology, a position he held until January 2008 when he was named Chief Information Officer. Mr. Harrison began his career in IT working for several private companies and consulting firms where he held several positions in technical support, sales and management capacities. Mr. Harrison received a Bachelor of Science degree in Business Administration with a minor in Computer Science from the University of Utah in 1994.

Jerry Lanchbury Ph.D.
Chief Scientific Officer
Jerry Lanchbury Myriad Genetics, Inc.

Jerry Lanchbury, Ph.D., Chief Scientific Officer, joined Myriad in September 2002. Dr. Lanchbury graduated from the University of Aston, Birmingham, UK. He earned his doctorate in population genetics from the University of Newcastle upon Tyne and subsequently completed his postdoctoral fellowship at the United Medical & Dental Schools of the University of London in Human Disease Genetics. Dr. Lanchbury is a highly respected expert in immunogenetics with more than 100 reviewed research journal publications.

Richard Marsh
Executive Vice President, General Counsel and Secretary
Richard Marsh Myriad Genetics, Inc.

Richard Marsh, Executive Vice President, General Counsel and Secretary joined Myriad in November 2002. Prior to joining Myriad, Mr. Marsh served in various positions at Iomega Corporation including Acting General Counsel, Director of IP and Director of Commercial Legal Affairs. Richard received a Masters of Laws degree in Taxation from Georgetown University Law Center; a law degree from Thomas M. Cooley Law School, graduating magna cum laude; and a Bachelor of Science degree in Accounting from Brigham Young University; and was formerly a Certified Public Accountant.













Stock Information
Ticker:MYGN
Exchange: NASDAQ
Last Trade: $21.67
Change: down 0.42
Volume: 2,195,400

Feb 8, 2010  3:59 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.